Caris Life Sciences (CAI) EPS (Weighted Average and Diluted) (2024 - 2026)
Caris Life Sciences (CAI) recorded quarterly EPS (Weighted Average and Diluted) of -$0.0 in Q1 2026, down 100.11% quarter-over-quarter from $1.61 in Q4 2025, and up 99.95% on a YoY basis from -$0.0 in Q1 2025.
Caris Life Sciences (CAI) EPS (Weighted Average and Diluted) (2024 - 2026) Analysis & Trends
Caris Life Sciences' EPS (Weighted Average and Diluted) history runs 3 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 99.95% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$6.28 (up 39.85% YoY), while the FY2025 annual figure was -$3.22, up 69.79% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.0 for Q1 2026 at Caris Life Sciences, down from $1.61 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.61 in Q4 2025 to a low of -$7.97 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$2.09 across 3 years, with a median of -$2.14 in 2024.
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 192.53% in 2025; the steepest drop was 213.78% in 2025.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.74 in 2024, then jumped by 192.53% to $1.61 in 2025, then sank by 100.11% to -$0.0 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q1 2026), $1.61 (Q4 2025), and $0.08 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 1.61 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | -7.97 |
| Mar 31, 2025 | -3.57 |
| Dec 31, 2024 | -1.74 |
| Sep 30, 2024 | -2.59 |
| Jun 30, 2024 | -2.54 |